roche - Search News

acne, La Roche-Posay and Walgreens

Some La Roche-Posay, Proactiv and Walgreens acne treatments recalled due to benzene levels

U.S. health officials are asking retailers to pull a small number of acne creams from their store shelves after government testing found they contain slightly elevated levels of a chemical associated with cancer.

NPR · 5h

Some acne treatments from brands like Walgreens, La Roche-Posay voluntarily recalled

The FDA tested 95 products containing benzoyl peroxide, an ingredient widely used to treat acne that can form benzene as a byproduct. It found that six products could have more benzene than usual.

Yahoo · 15h

Why La Roche-Posay is pulling this acne treatment, and why you shouldn't use it

Parent company La Roche-Posay has pulled the Effaclar Duo Acne Spot Treatment from L'Oreal's lineup, due to a cancer-causing carcinogen contamination.

Zealand Pharma to pay $350M to Roche

Reuters on MSN · 1d

Roche secures Zealand obesity drug candidate for up to $5.3 billion

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker seeks to boost its prospects in the booming weight-loss market.

Business Insider · 1d

Zealand Pharma to pay $350M to Roche in petrelintide collaboration, license pact

Zealand Pharma (ZLDPF) and Roche (RHHBY) entered a collaboration and license agreement to co-develop and co-commercialize petrelintide as a

Bloomberg L.P. · 2d

Roche, Zealand Pharma in $5.3 Billion Pact for Obesity Drugs

Roche Holding AG licensed a new weight-loss drug from Zealand Pharma A/S for as much as $5.3 billion, bolstering the Swiss drugmaker’s effort to get into a hot market dominated by Novo Nordisk A/S and Eli Lilly & Co.

1don MSN

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal

Roche Holding said it would pay Danish biotechnology research company Zealand Pharma up to $5.3 billion under an agreement to ...

BioSpace2d

Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit

In connection with Spark’s overhaul, Roche will incur approximately $2.4 billion in goodwill impairment costs. This sum takes ...

1don MSN

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

The Punch on MSN9h

Roche, Oncopadi tech to support 5,000 breast cancer patients

A multinational healthcare company, Roche and a provider of digital integrated healthcare services, Oncopadi Technologies ...

Roche to open innovation center at new Harvard campus in Allston that could employ hundreds

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise ...

Fierce Biotech1d

Roche pads out obesity pipeline, paying Zealand $1.6B upfront to codevelop amylin asset

Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning obesity pipelin | Roche is paying $1.65 ...

14h

ROCHE BOBOIS: MONTHLY NEWSLETTER - FEBRUARY 2025

Roche Bobois, the global leader in the high-end furniture market and the epitome of the French Art de Vivre, publishes its latest news every month. FEBRUARY 2025 LATEST NEWS PENINSULA PARIS ...

22h

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Beam Therapeutics (BEAM)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

acne, La Roche-Posay and Walgreens

Zealand Pharma to pay $350M to Roche

Related topics